Back to results
US 8,278,318 B2Granted
Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
AssigneeIncyte Corporation
InventorsWenqing Yao, Jincong Zhuo, Colin Zhang
Life of this patent
Estimating the term…
Abstract
The present invention relates to certain spirocyclic compounds that are inhibitors of 11-β hydroxyl steroid dehydrogenase type 1 (11βHSD1), compositions containing the same, and methods of using the same for the treatment of diabetes, obesity and other diseases.
Claims6
A compound which is:
- 5-{3-Fluoro-4-[(5S)-2-(cis-4-hydroxycyclohexyl)-1-oxo-2,7-diazaspiro[4.5]dec-7-yl]phenyl}-N,N-dimethylpyridine-2-carboxamide;
- or a pharmaceutically acceptable salt thereof.
A compound which is:
- 5-{3-Fluoro-4-[(5S)-2-(cis-4-hydroxycyclohexyl)-1-oxo-2,7-diazaspiro[4.5]dec-7-yl]phenyl}-N-methylpyridine-2-carboxamide;
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.